The development of Live Biotherapeutic Products (LBPs) targeting the human gut microbiota represents a frontier in precision medicine. Among the candidates, Faecalibacterium duncaniae (a member of the Faecalibacterium prausnitzii phylogroup) is recognized for its significant anti-inflammatory properties and its role as a biomarker for intestinal health. However, its extreme sensitivity to oxygen (XOS) poses substantial challenges for large-scale production and therapeutic delivery. Recent academic inquiries have focused on the metabolic precursors that might mitigate oxidative damage, with Cobalamin (Vitamin B12) emerging as a critical factor.
This article provides an objective analysis of recent findings regarding Cobalamin-mediated protection in F. duncaniae through proteomic and membrane fatty acid (MFA) profiling. For researchers and pharmaceutical developers aiming to translate these complex biological mechanisms into stable therapeutic products, Creative Biolabs offers an end-to-end service platform. By integrating advanced anaerobic cultivation, multi-omics characterization, and formulation optimization, we empower our partners to overcome the technical bottlenecks inherent in Next-Generation Probiotic (NGP) development. Contact our scientists today to initiate your project discussion.
Faecalibacterium duncaniae (formerly classified within Faecalibacterium prausnitzii phylogenetic clades) is an abundant, butyrate-producing commensal bacterium essential for intestinal homeostasis. However, its strict anaerobic nature makes it highly susceptible to reactive oxygen species (ROS) during gut inflammation and industrial processing. This study systematically explored the physiological and molecular adaptations of F. duncaniae A2-165 under hydrogen peroxide (H₂O₂)-induced oxidative stress conditions.
Experimental Design and Methodologies
The study concludes that F. duncaniae employs a complex, multifaceted defensive strategy to withstand oxidative stress. Crucially, cobalamin serves as a critical cytoprotective agent that limits oxidative damage, scavenges superoxides, and stabilizes membrane structure, offering a clear molecular blueprint for improving the environmental resilience of oxygen-sensitive therapeutic strains.
To replicate or build upon these findings for commercial LBP development, several technical requirements emerge. Creative Biolabs provides specialized services designed to meet these specific R&D needs:
Creative Biolabs maintains an extensive portfolio of ready-to-use laboratory reagents and reference standards through our dedicated product catalog:
Partnering with Creative Biolabs allows global researchers to leverage an industry-leading technical infrastructure tailored specifically to next-generation live biotherapeutic challenges:
From initial strain characterization and omics analysis to scale-up fermentation and formulation, we handle every stage of the LBP lifecycle.
Our laboratories are equipped with advanced anaerobic chambers and bioreactors capable of maintaining oxygen levels < 1 ppm, ensuring the integrity of XOS samples.
Unlike traditional probiotic CROs, we have extensive experience specifically with "difficult-to-culture" organisms like Faecalibacterium, Akkermansia, and Bacteroides.
All studies are performed with rigorous documentation suitable for inclusion in IND (Investigational New Drug) applications for LBPs.
The insights gained from studying Cobalamin-mediated protection in F. duncaniae have far-reaching implications across several therapeutic and commercial domains:
Unraveling the molecular protective effects of cobalamin on Faecalibacterium duncaniae underscores the power of multi-omics approaches in overcoming the environmental vulnerabilities of next-generation probiotics. Creative Biolabs serves as a comprehensive, specialized technical bridge from academic discovery to commercializable live biotherapeutic products. Our end-to-end contract research services, spanning anaerobic characterization, functional omics, strain modification, and formulation development, alongside our high-purity catalog reagents, provide innovators with the resources required to de-risk and accelerate their LBP development programs.
While F. duncaniae cannot synthesize B12, it possesses transport mechanisms to import it. B12 acts as a cofactor for enzymes involved in DNA synthesis and metabolic pathways that are less sensitive to oxidative stress, effectively acting as a "metabolic shield."
We offer comprehensive TMT-labeled, DIA (Data-Independent Acquisition), and PRM (Parallel Reaction Monitoring) proteomics to provide both broad discovery and targeted quantification of stress-response proteins.
Our technical team can provide strain identification and comparative genomic services to help you select the most relevant phylogroup based on your specific therapeutic target.
We provide a comprehensive range of standardized, off-the-shelf DNA standards and inactivated references listed in our catalog for rapid deployment. Additionally, we offer custom extraction and inactivation services for proprietary strains provided directly by our clients.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Copyright © 2026 Creative Biolabs. All Rights Reserved.